Zhende Medical Co., Ltd. (SHA:603301)
China
· Delayed Price · Currency is CNY 19.14
-0.01 (-0.05%)
Apr 30, 2025, 3:00 PM CST
Zhende Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 397.21 | 198.4 | 679.88 | 595.86 | 2,549 | Upgrade
|
| Depreciation & Amortization | 246.52 | 239.57 | 194.28 | 139.3 | 78.57 | Upgrade
|
| Other Amortization | 1.27 | 4.73 | 1.05 | 3.76 | 0.37 | Upgrade
|
| Loss (Gain) From Sale of Assets | -93.43 | 15.96 | 13.53 | 0.61 | -0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 57.98 | 54.32 | 8.88 | 3.31 | 48.4 | Upgrade
|
| Loss (Gain) From Sale of Investments | -11.07 | -12.42 | 60.17 | -34.03 | -11.56 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 1.8 | 8.6 | 1.44 | 17.76 | Upgrade
|
| Other Operating Activities | 14.66 | 214.65 | 116.03 | 198.18 | 588.81 | Upgrade
|
| Change in Accounts Receivable | -255.37 | 307.45 | -127.95 | 49.71 | -468.07 | Upgrade
|
| Change in Inventory | -10.44 | -12.7 | -228.71 | 279.07 | -659.32 | Upgrade
|
| Change in Accounts Payable | 100.42 | -536.27 | 507.89 | -426.96 | 995.44 | Upgrade
|
| Change in Other Net Operating Assets | - | 5.22 | 17.34 | 23.6 | - | Upgrade
|
| Operating Cash Flow | 461.14 | 452.11 | 1,246 | 817.63 | 3,121 | Upgrade
|
| Operating Cash Flow Growth | 2.00% | -63.72% | 52.40% | -73.80% | 1478.07% | Upgrade
|
| Capital Expenditures | -769.69 | -599.24 | -754.12 | -695.47 | -1,093 | Upgrade
|
| Sale of Property, Plant & Equipment | 121.59 | 12.61 | 9.58 | 6.78 | 67.72 | Upgrade
|
| Cash Acquisitions | -48.66 | -311.91 | -77.09 | -545.54 | -92.33 | Upgrade
|
| Divestitures | - | - | 51.57 | - | - | Upgrade
|
| Investment in Securities | -74.85 | -159.25 | -216.68 | 674.44 | -687 | Upgrade
|
| Other Investing Activities | 3.62 | -0.07 | -6.05 | 5.36 | 14.22 | Upgrade
|
| Investing Cash Flow | -767.99 | -1,058 | -992.79 | -554.42 | -1,790 | Upgrade
|
| Short-Term Debt Issued | - | 20.28 | 41.55 | - | - | Upgrade
|
| Long-Term Debt Issued | 1,419 | 916.9 | 1,839 | 885 | 945 | Upgrade
|
| Total Debt Issued | 1,419 | 937.18 | 1,880 | 885 | 945 | Upgrade
|
| Short-Term Debt Repaid | - | -16.38 | - | - | -41.18 | Upgrade
|
| Long-Term Debt Repaid | -1,395 | -920.36 | -1,992 | -541.26 | -892.1 | Upgrade
|
| Total Debt Repaid | -1,395 | -936.74 | -1,992 | -541.26 | -933.28 | Upgrade
|
| Net Debt Issued (Repaid) | 24.26 | 0.43 | -112.05 | 343.74 | 11.72 | Upgrade
|
| Issuance of Common Stock | - | - | 1,018 | 52.5 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -113.15 | -133.38 | - | Upgrade
|
| Common Dividends Paid | -159.4 | -423.72 | -164.25 | -543.65 | -78.31 | Upgrade
|
| Other Financing Activities | -34.3 | - | -172.96 | -98.77 | -211.08 | Upgrade
|
| Financing Cash Flow | -169.43 | -423.28 | 456 | -379.57 | -277.66 | Upgrade
|
| Foreign Exchange Rate Adjustments | 21.2 | 12.81 | -3.7 | -38.29 | -96.66 | Upgrade
|
| Net Cash Flow | -455.07 | -1,016 | 705.55 | -154.65 | 956.35 | Upgrade
|
| Free Cash Flow | -308.55 | -147.13 | 491.92 | 122.16 | 2,028 | Upgrade
|
| Free Cash Flow Growth | - | - | 302.68% | -93.98% | - | Upgrade
|
| Free Cash Flow Margin | -7.24% | -3.56% | 8.02% | 2.40% | 19.50% | Upgrade
|
| Free Cash Flow Per Share | -1.16 | -0.55 | 2.08 | 0.54 | 9.94 | Upgrade
|
| Cash Income Tax Paid | 76.7 | 164.58 | 38.26 | 475.64 | 351.58 | Upgrade
|
| Levered Free Cash Flow | -444.47 | -338.45 | 226.69 | -336.72 | 1,034 | Upgrade
|
| Unlevered Free Cash Flow | -444.47 | -320.37 | 247.65 | -321.05 | 1,046 | Upgrade
|
| Change in Net Working Capital | 193.84 | 116.47 | -278.79 | 237.68 | 219.08 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.